Providing persons living with AD/ADRD and their caregivers and care partners with plenty of opportunities to ask questions, reiterating important trial details throughout the entirety of their involvement, as well as clearly communicating the risks and benefits of participation, are all strategies that can help people feel more empowered to make informed decisions and reduce some of the uncertainties and anxieties surrounding clinical trial enrollment (Connell et al., 2001
Facial flushing and headache can occur initially
To maintain sustained results, some switch to a lower dose after 1218 months, but only under a doctors guidance
Chronic high-carbohydrate diets, gut dysbiosis, inflammation, aging, and metabolic dysfunction can all impair L-cell function and reduce GLP-1 secretion
These numbers help you evaluate value